Who has invested in HTG Molecular Diagnostics?

Merck & Co are named among the investors backing HTG Molecular Diagnostics.

HTG Molecular Diagnostics Funding: $38M Raised, IPO (2014)

HTG Molecular Diagnostics funding overview

HTG Molecular Diagnostics is based in Tucson. HTG Molecular Diagnostics has raised $38M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is an IPO announced in November 2014. The round record for HTG Molecular Diagnostics runs through 2014; nothing later has been disclosed. Investors on record include Merck & Co.

HTG Molecular Diagnostics at a glance

Total raised: $38M
Latest round: IPO
Latest round date: November 2014
Headquarters: Tucson
Notable investors: Merck & Co

Frequently asked about HTG Molecular Diagnostics funding

How much has HTG Molecular Diagnostics raised?: HTG Molecular Diagnostics has raised $38M in total disclosed funding across the rounds on record.
Who has invested in HTG Molecular Diagnostics?: Merck & Co are named among the investors backing HTG Molecular Diagnostics.
What was the latest HTG Molecular Diagnostics funding round?: The most recent disclosed round is an IPO, announced in November 2014.
Where is HTG Molecular Diagnostics based?: HTG Molecular Diagnostics is based in Tucson.
When did HTG Molecular Diagnostics last raise?: The last disclosed HTG Molecular Diagnostics round closed in November 2014 at IPO.

Round data for HTG Molecular Diagnostics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Tucson and backer lists below.

HTG Molecular Diagnostics Funding: $38M Raised, IPO (2014)

HTG Molecular Diagnostics funding overview

HTG Molecular Diagnostics at a glance

Frequently asked about HTG Molecular Diagnostics funding

Companies related to HTG Molecular Diagnostics (34)

Browse related funding lists (3)